QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 0.69887
-- x --
-- x --
-- - --
$ 0.25 - $ 1.13
361,752
na
na
$ 1.18
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 enzo-biochem-q4-eps-001-sales-753m-cash-524m

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.01) per share. The company reported $7.53 million in sales this quarter.

 enzo-biochem-ordered-to-pay-45m-for-failing-to-protect-patient-data

- Reuters Citing NY Attorney General

 why-pricesmart-shares-are-trading-higher-by-around-5-here-are-20-stocks-moving-premarket

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expecte...

 heico-emcor-group-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as fol...

 enzo-biochem-q1-eps-013-up-from-022-yoy

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.13) per share. This is a 40.91 percent increase over losses of $(0.22)...

 enzo-biochem-announces-departure-of-hamid-erfanian-and-appointment-of-kara-cannon-as-interim-ceo-effective-september-5-2023

 Enzo Biochem, Inc. (NYSE:ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION